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Abstract
Background: Little is known about the effect of multiple, or subsequent, ischemic strokes in patients receiving
hemodialysis.
Methods: We undertook a retrospective cohort study of incident hemodialysis patients with Medicare coverage
who had experienced a first ischemic stroke. Factors associated with either a subsequent ischemic stroke or death
following a first new stroke were modeled. A multistate model with Cox proportional hazards was used to predict
transition probabilities from first ischemic stroke to either subsequent stroke or to death, and the demographic and
clinical factors associated with the respective transition probabilities were determined. Effect of a subsequent
ischemic stroke on survival was quantified.
Results: Overall, 12,054 individuals (mean age 69.7 years, 41.3 % male, 53.0 % Caucasian and 34.0 % African-American)
experienced a first new ischemic stroke. Female sex was associated with an increased risk of having a subsequent
ischemic stroke (adjusted hazard ratio 1.37, 95 % confidence intervals 1.20 – 1.56, P < 0.0001); African-Americans, as
compared to Caucasians, had lower likelihood of dying after a first new ischemic stroke (0.81, 0.77 – 0.85, P < 0.0001).
A subsequent stroke trended towards having a higher likelihood of transitioning to death compared to a first new
ischemic stroke on dialysis (1.72, 0.96 – 3.09, P = 0.071). When a subsequent ischemic stroke occurs at 24 months,
probability of survival dropped >15 %, in absolute terms, from 0.254 to 0.096, with substantial drops observed at
subsequent time points such that the probability of survival was more than halved.
Conclusions: Likelihood of subsequent ischemic stroke and of survival in hemodialysis patients appears to vary by sex
and race: females are more likely than males to experience a subsequent ischemic stroke, and Caucasians are more
likely than African-Americans to die after a first new ischemic stroke. The risk of a transitioning to a subsequent stroke
(after having had a first) increases until about 1 year, then decreases. Subsequent strokes are associated with decreased
probability of survival, an effect which increases as time since first stroke elapses. This information may be of assistance
to clinicians when counseling hemodialysis patients about the implications of recurrent ischemic stroke.
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Background
Stroke, a catastrophic health event with profound implica-
tions for morbidity and mortality, impacts both the indi-
vidual and society as a whole [1]. Like virtually all
cardiovascular events, stroke is especially common in pa-
tients receiving chronic dialysis, with many reports having
helped to quantify the incidence and prevalence of stroke
[2–8], its geographic variation in the U.S. [9], and its asso-
ciation with mortality and years of life lost [10].
However, there is little information about multiple, or
repeat, ischemic strokes in hemodialysis (HD) patients.
Individuals who experience multiple strokes might differ
in substantial ways from those who only ever have a sin-
gle stroke, and the clinical implications of a repeat, or
subsequent, stroke on mortality is unknown. To ascer-
tain how often subsequent ischemic strokes occur in HD
patients, which factors might be associated with subse-
quent strokes, and how such strokes are associated with
mortality, we constructed a large cohort of incident HD
patients using data from the United States Renal Data
System (USRDS) and Medicare. We employed a novel
multi-state modeling approach to investigate how demo-
graphic characteristics might be associated with subse-
quent strokes and post-stroke survival, and how the risk
of death after a first ischemic stroke compared to risk of
death after a subsequent one. We hypothesized that the
hazard ratio for mortality would increase for a subse-
quent, as compared to an initial, ischemic stroke.
Findings in this area could ultimately improve the un-
derstanding of stroke-related mortality in patient receiv-
ing HD, provide data with which to counsel patients,
and better guide future stroke-awareness and -preven-
tion efforts among patients, healthcare providers, and
the dialysis community.
Methods
Study design, cohort, and data sources for analysis
We performed a retrospective cohort analysis of incident,
chronic HD patients who were >18 years of age, initiated
dialysis on or after January 1, 2000 through October 2,
2005, were continuously enrolled in Medicare, had a mini-
mum of 90 days of follow-up after cohort inclusion, and
who had had a stroke on or after day 91 of HD. Medicare,
a federally-funded program for which nearly all adults
with end stage renal disease are entitled, insures the vast
majority of chronic dialysis patients [2, 11]. Patients en-
rolled in managed care plans or in the Department of Vet-
erans Affairs health system were excluded.
Data for these analyses were from the USRDS, a na-
tional system that collects data on virtually all patients
undergoing chronic dialysis in the U.S. From the USRDS,
we received standard patient records that included demo-
graphics and comorbidities at the time of dialysis com-
mencement. The USRDS also incorporates data on
inpatient and outpatient medical claims paid by Medicare,
which contain International Classification of Diseases –
9th Revision (ICD-9) codes for each date of service.
To assure that we were studying chronic HD patients
and to help establish the presence of comorbidities, pa-
tients were required to initially survive 90 days; first new
strokes could therefore occur, at the earliest, on day 91.
All patients who had a first new stroke then constituted
the analytic cohort, or “risk pool”, for subsequent stroke
and death events. Individuals were then censored upon
loss of Medicare coverage, or receipt of a kidney trans-
plant on or before December 31, 2005.
Covariates and descriptive variables
Demographic and clinical variables were drawn from the
CMS 2728 Medical Evidence Form and supplemented by
Medicare claims. These included age, sex, race by ethni-
city, body mass index, employment status, smoking, sub-
stance abuse (alcohol or illicit drugs), inability to
ambulate and to transfer, cause of ESRD, and comorbidi-
ties. Age was treated as a time-dependent covariate (i.e.,
it was assessed at first stroke and again later at second
stroke, if it occurred). Race/ethnicity was categorized
into one of four mutually exclusive groups: non-
Hispanic Caucasians, non-Hispanic African-Americans,
Hispanics, and Others. Body mass index (BMI) was clas-
sified into 4 categories: < 20 kg/ m2, 20–24.99 kg/m2,
25–29.99 kg/m2, ≥ 30 kg/m2. Cause of ESRD was cate-
gorized as diabetes, hypertension, glomerulonephritis, or
other. Because the CMS 2728 form is structured such
that diabetes and hypertension may be considered as
both a cause of ESRD and/or a “freestanding” comorbid-
ity, for the purposes of the present analysis, these two
covariates were considered a comorbidity if they were
listed as either the cause of ESRD or as a freestanding
comorbidity on the CMS 2728 form [12]. Initial comor-
bidities, ascertained at dialysis initiation from the CMS
2728 form, consisted of diabetes, congestive heart fail-
ure, coronary artery disease, cerebrovascular disease, and
peripheral vascular disease. We did not censor patients
if they changed to peritoneal dialysis.
Stroke identification
We utilized recent information on the sensitivity and
specificity of stroke-related ICD-9 claims [13] to identify
ischemic strokes from Medicare data, as has been done
previously by Go et al. [9, 14] Briefly, a patient was con-
sidered to have an ischemic stroke if the principal diag-
nosis ICD-9 code at the time of hospital discharge was
434 or 436 and one of the following occurred: (a) the pa-
tient expired during the hospitalization; (b) the
hospitalization lasted ≥ 48 h; or (c) the hospitalization
lasted < 48 h and the patient did not have a carotid end-
arterectomy (ICD-9 code 381.2). In the absence of 434
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or 436, ICD-9 code 362.3 was sufficient to diagnose an
ischemic stroke. To establish the analytic cohort (risk
pool), all individuals had to experience a first new stroke
on or after day 91 of dialysis (i.e., after having survived
the first 90 days of dialysis). Subsequent strokes were
not only identified using the same complex algorithm,
but also had to be separated by at least 30 days from a
previous stroke event, in order to reduce the likelihood
of misclassification resulting from a readmission for a
previous stroke. No minimum time was established be-
tween stroke and death; the latter could occur immedi-
ately as a result of the former. Causes of death were not
considered; we sought only to determine the relationship
between stroke and subsequent all-cause mortality.
Statistical analyses
We generated descriptive statistics to illustrate how indi-
viduals who experienced subsequent ischemic stroke dif-
fered from those who experienced a first ischemic
stroke. Bivariate analyses comparing each of the explana-
tory variables were performed using Pearson’s chi-
squared test or Student’s t-test, as appropriate.
We modelled survival following a first or subsequent is-
chemic stroke using a multistate modeling approach.
(Thus, by definition, all studied individuals had to experi-
ence a first stroke, which constituted “time zero”.) The
multistate modeling approach permits modeling of the
hazard of transitioning from one state to the next possible
state using the familiar Cox proportional hazards (PH)
framework. Specifically, with this approach, an individual
is conceptualized as being in one of the three possible
states: alive after having had only a first stroke; alive after
having had a subsequent stroke; or dead. Accordingly,
there are three possible types of accompanying transitions
(Fig. 1), with censoring possible in any of these three tran-
sitions and modeling in each of these transitions is done
using the Cox PH model. The advantage of using this ap-
proach is that for states that transition to the terminal out-
come (i.e., death), the Cox PH model can be used to
estimate the hazard ratio of death for experiencing a
subsequent stroke compared to experiencing only the first
stroke after adjusting for the effect of clinically significant
covariates specific to that transition. In this context, sub-
sequent stroke is treated as a time-dependent covariate,
i.e., it may or may not occur at some time after first stroke
en route to death [15–17]. Equivalence between a multi-
state model with a single intermediate state (such as ours)
as a Cox model with a single time-dependent covariate
has been illustrated by Putter et al. [15] We explicitly
tested whether the assumptions of the proportional haz-
ards modeling approach were valid by including an add-
itional term assessing the “effect” of subsequent stroke
over time (i.e., testing for a stroke-by-time interaction),
but, finding this to interaction to be nonsignificant, we re-
ported the more parsimonious model.
One advantage of this approach, which has been used to
investigate clinical issues previously [16], is that it allows
the other baseline risk factors to have different (or “freely
varying”) effects in each transition, which is theoretically
appealing because it is possible that baseline comorbidities
may play a different role in likelihood of mortality based on
whether a patient has experienced only one stroke or more
than one stroke. In the case of a relatively small number of
subsequent events (such as subsequent strokes, which were
pooled from second and third strokes), this approach also
permits the flexibility to fit parsimonious models for the
baseline covariates in each transition and defends against
model over-fitting. This is done by first fitting a full model
with all covariates (in each transition) and then sequentially
deleting those covariates that are not found to be statisti-
cally significant. This process is continued until a parsimo-
nious model that includes only statistically significant
predictors is generated. By appropriately combining the es-
timated baseline hazards and the regression coefficients it is
possible to calculate the (predicted) transition probability of
moving from state “A” to state “B” in time interval (s, t] as
outlined in Klein et al. [18] This is done by first estimating
the baseline cumulative hazard, adjusting it for the effect of
covariates, and using it to estimate survival probabilities in
each transition. These estimated survival probabilities are
then used to estimate the (predicted) transition probabilities
by using the appropriate integration formulas. For example,
in the case of moving from “first stroke” to “subsequent
stroke”, the transition probability is the probability of ex-
periencing a recurrent stroke in interval (0, t] given that the
patient starts at time = 0 with one stroke. For the case of
moving from “first stroke” to “death”, it is the probability of
dying in interval (0, t] given that the patient started at time
= 0 with one stroke. (That is, a patient could die directly
after only one stroke in this interval or die via experiencing
second stroke.) This approach facilitates calculation of pre-
dicted probabilities of being in any given state at any time
after cohort entry and permits clinically meaningful infer-
ences to be made. As Cox PH models are used in each
Fig. 1 The multistate model and transitions of the participants
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transition, the proportionality of hazards assumption for all
the categorical predictors in the model was assessed by
means of a log-log survival plot. In addition to being able to
incorporate the time-dependent nature of a events such as
a subsequent stroke, this method allows the flexibility in
the use of baseline risk factors affecting the likelihood of
mortality differently in each transition. Parsimonious
models (in terms of covariates) can be fit, while use of the
Cox proportional hazards framework facilitates calculates
probabilities of transition from the current state to the next
state within a given time interval.
For all analyses, P < 0.05 was considered statistically
significant. The 95 % confidence intervals were obtained
using Wald formulas. All statistical analyses utilized R
statistical software, with the “mstate package” being used
specifically for the main analyses [17].
At all times, we adhered to the STrengthening the
Reporting of OBservational studies in Epidemiology
(STROBE) guidelines in the design, analysis, and report-
ing of this study.
Compliance and protection of human research
participants
The research protocol was approved by the institutional
review board at the University of Kansas Medical Center
(KUMC). Data Use Agreements (DUA) between KUMC
and the USRDS and CMS were in place.
Results
Cohort characteristics
Figure 2 shows the construction of the cohort. There were
12,054 individuals who satisfied all inclusion criteria and
who experienced a new stroke on or after day 91 of
hemodialysis, thereby forming the analytic cohort. Mean
age was 69.7 years, 41.3 % were male, and 53.0 % were
Caucasian while 34.0 % were African-American.
Of the 12,054 who experienced a first stroke, 2771
(23.0 %) were alive at time of censoring (“remained in
state”) a mean of 12.5 ± 13.8 months after their stroke;
967 (8.0 %) transitioned to a subsequent stroke a mean
of 10.3 ± 9.9 months after their first stroke, and 8316
(69.0 %) died a mean of 9.8 ± 12.0 months their stroke
(Fig. 1). Of those who experienced a subsequent stroke,
78.4 % subsequently died a mean of 7.8 ± 9.9 months
after the subsequent stroke.
Persons were divided into those who experienced one
stroke and those who experienced > 1 stroke; their charac-
teristics are shown in Table 1. In general, individuals who
experienced > 1 stroke were marginally younger, more
likely to be female, more likely to be African-American
(compared to Caucasian), more likely to have diabetes,
and more likely to have had a previous stroke before en-
tering the cohort and to have permanent atrial fibrillation.
The multistate model: factors associated transitions to
future ischemic stroke and to death
The results of the multistate model, which by design
models both factors associated with subsequent strokes
and survival following (separately) a first or subsequent
stroke, are shown in Table 2; this model is adjusted for all
factors listed in Table 1. Increasing age was associated
with likelihood of transitioning from either a first (per-
decade AHR 1.26, 95 % CIs 1.24 – 1.29, P < 0.0001) or sec-
ond (1.40, 1.30 – 1.50, P < 0.0001) stroke to death, while
female sex was associated with an increased risk of having
a subsequent stroke (1.37, 1.20 – 1.56, P < 0.0001).
African-Americans, as compared to Caucasians, had lower
likelihood of dying after a first stroke (0.81, 0.77 – 0.85, P
< 0.0001). A low BMI (<20 kg/m2) was associated with an
increased likelihood of dying after a first stroke (1.19, 1.11
– 1.28, P < 0.0001), while higher BMI categories (25 –
29.99 kg/m2 and ≥ 30 kg/m2) were associated with a lower
risk of death after either first (0.91, 0.86 – 0.97, P = 0.0012
and 0.72, 0.61 – 0.86, P = 0.0002, respectively) or second
(0.92, 0.87 – 0.97, P = 0.0038 and 0.80, 0.67 – 0.96, P =
0.018, respectively) stroke. Diabetics were at increased risk
of death after a first stroke (1.07, 1.02 – 1.12, P = 0.0070).
A stroke prior to cohort entry tended to be associated
with increased likelihood of experiencing a subsequent
stroke (1.13, 1.00 - 1.29, P = 0.052), although previous
strokes prior to cohort entry (e.g., during the predialysis
period) were associated with lower likelihood of transition-
ing to death after either first or second strokes (0.54, 0.52 -
0.57, P < 0.0001 and 0.62, 0.54 - 0.72, P < 0.0001, respect-
ively). After adjustment for all factors listed in Table 2, a
subsequent stroke trended towards having a higher likeli-
hood of resulting in transitioning to death compared to a
first new stroke (1.72, 0.96 - 3.09), but this was of only bor-
derline statistical significance (P = 0.071). In a sensitivity
analysis in which we eliminated all individuals who experi-
enced a stroke in the first 90 days after dialysis initiation
(that is, before they satisfied criteria to be in the analytic co-
hort), results trended in the same direction, with the likeli-
hood of transitioning to death compared to a first new
stroke being 1.58 (0.74 - 3.39, P = 0.24).
Temporal changes in the probabilities of transitioning
from first ischemic stroke to a subsequent ischemic
stroke or death
A “stacked transition probability graph” is shown in
Fig. 3, which demonstrates the probability of transition-
ing between different states (e.g., from first stroke to
subsequent stroke, from first stroke to death, and
remaining alive after having had only 1 stroke); a table
of transition probabilities between states, shown as time
elapses after first new stroke, accompanies the figure. As
can been seen, probability of transition to death in-
creased as time elapses, as expected. However, the
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probability of transitioning to a subsequent stroke in-
creased most sharply over the first 6 months, rose more
slowly until reaching a peak at approximately 12 months,
then declined steadily as time elapses.
Timing of a subsequent ischemic stroke and resultant
survival probabilities
The effect of a subsequent stroke, generated for the
sample-based average risk profile for the cohort, is shown
in another way in Fig. 4, which demonstrates the impact
on survival of a subsequent stroke. The initial survival
curve (that representing survival after a first stroke) gener-
ates a trajectory, the change of which is then modelled
and demonstrated by a subsequent stroke which occurs at
a subsequent time; 12, 24, and 36 months have been se-
lected for demonstration purposes. When a subsequent
stroke occurred at 24 months, probability of survival de-
creased >15 %, in absolute terms, from 0.254 to 0.096. A
substantial drop was seen at subsequent time points (e.g.,
36 months), in each case leaving less than half of the
remaining probability of survival.
Discussion
In this study, we examined recurrent strokes in patients
receiving chronic dialysis. In patients who had experi-
enced a first stroke on dialysis, we sought to determine
Fig. 2 Construction of the analytic cohort
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what factors were associated with subsequent strokes
and to assess the relative hazard for death of a subse-
quent stroke compared to an initial one. Since patients
with an initial stroke can remain alive without a subse-
quent stroke, experience a subsequent stroke, or die
after either of a first or subsequent stroke, we reasoned
that a multistate model was a suitable approach to inves-
tigate these questions. Our principal findings were that
females had a substantially increased risk of subsequent
stroke compared to males; that African-Americans had
greater survival after a first new stroke than Caucasians;
that the likelihood of experiencing a second stroke, com-
pared to remaining alive after a first new stroke or dying,
increases rapidly over the first 6 months but later dimin-
ishes; and that a subsequent stroke markedly decreases
survival probability and tends to be associated with in-
creased risk of mortality relative to a first new stroke.
The issue of subsequent or multiple stokes has not been
well-addressed in the dialysis literature; indeed, data is
somewhat sparse even in the nondialysis population [19].
While a substantial body of work has been compiled re-
garding stroke in dialysis patients [3–10, 20–23], the rela-
tive effects of subsequent strokes appears not to have been
specifically studied. The overall number of subsequent
Table 2 Adjusted hazard ratios of covariates for the multistate
model
AHR 95 % CI’s P-Value
Age (per decade) stroke 1→ death 1.26 1.24 – 1.29 <0.0001
Age (per decade) stroke 2→ death 1.40 1.30 – 1.50 <0.0001
Female sex stroke 1→ stroke 2 1.37 1.20 – 1.56 <0.0001
Racea AA stroke 1→ death 0.81 0.77 – 0.85 <0.0001
Racea Other stroke 2→ death 0.55 0.34 – 0.88 0.013
BMIb <20 kg/m2stroke 1→ death 1.19 1.11 – 1.28 <0.0001
BMIb 25–29.9 kg/m2stroke 1→ death 0.91 0.86 – 0.97 0.0012
BMIb 25–29.9 kg/m2stroke 2→ death 0.72 0.61 – 0.86 0.0002
BMIb ≥30 kg/m2stroke 1→ death 0.92 0.87 – 0.97 0.0038
BMIb ≥30 kg/m2stroke 2→ death 0.80 0.67 – 0.96 0.018
Diabetes stroke 1→ death 1.07 1.02 – 1.12 0.0070
CHF stroke 1→ death 1.19 1.14 – 1.24 <0.0001
PVD stroke 2→ death 1.29 1.09 – 1.55 0.0044
Previous strokecstroke 1→ stroke 2 1.13 1.00 – 1.29 0.052
Previous strokecstroke 1→ death 0.54 0.52 – 0.57 <0.0001
Previous strokecstroke 2→ death 0.62 0.54 – 0.72 <0.0001
Smoker stroke 2→ death 2.14 1.50 – 3.03 <0.0001
Unemployed stroke 1→ death 1.35 1.10 – 1.66 0.0040
Inability to amb stroke 1→ death 1.22 1.09 – 1.36 0.0004
Inability to trans stroke 1→ death 1.22 1.03 – 1.44 0.021
Subsequent stroke stroke 1→ death
d 1.72 0.96 – 3.09 0.071
Abbreviations: AA African-American, BMI body mass index, CHF congestive
heart failure, PVD peripheral vascular disease, amb ambulate, trans transfer
aReference category for race is caucasians
bReference category for BMI is 20–24.9 kg/m2
cRepresent a stroke prior to cohort inclusion, specifically a stroke before day
90 of dialysis
dRepresents the risk of progressing to death via a second stroke versus
progressing to death after only having had one stroke after entering the
cohort. Thus, represents the adjusted hazard ratio for death of the second
stroke compared to the first
Table 1 Descriptive characteristics of the dually-eligible cohort,
by stroke status
Characteristica One Stroke Only >1 Stroke
No. of persons 11087 967
Age, yr 69.8 (11.8) 68.4 (10.8)
Male 4640 (41.9 %) 342 (35.4 %)
Race/Ethnicity
African-Amer. 3718 (33.5 %) 376 (38.9 %)
Caucasian 5912 (53.3 %) 471 (48.7 %)
Hispanic 1063 (9.6 %) 92 (9.5 %)
Other 394 (3.6 %) 28 (2.9 %)
BMI category
< 20 kg/m2 1170 (10.6 %) 83 (8.6 %)
20 –24.9 kg/m2 3696 (33.3 %) 297 (30.7 %)
25 –29.9 kg/m2 3197 (28.8 %) 312 (32.3 %)
≥ 30 kg/m2 3024 (27.3 %) 275 (28.4 %)
Smoker 500 (4.5 %) 40 (4.1 %)
Substance abuser 137 (1.2 %) 14 (1.5 %)
Unemployed 10924 (98.5 %) 948 (98.0 %)
Unable to ambulate 659 (5.9 %) 55 (5.7 %)
Unable to transfer 261 (2.4 %) 23 (2.4 %)
Hb < 11.0 g/dLb 7540 (68.0 %) 652 (67.4 %)
Comorbidities
HTN 9668 (87.2 %) 856 (88.5 %)
DM 6794 (61.3 %) 645 (66.7 %)
CHF 4324 (39.0 %) 352 (36.4 %)
CAD 3715 (33.5 %) 303 (31.3 %)
PVD 2066 (18.6 %) 189 (19.5 %)
Prior CVA 4429 (40.4 %) 533(55.1 %)
Permanent AF 2470 (22.3 %) 229 (23.7 %)
Cause of ESRD
DM 6014 (54.2 %) 584 (60.4 %)
HTN 3019 (27.2 %) 233 (24.1 %)
GN 500 (4.5 %) 35 (3.6 %)
Other 1554 (14.0 %) 115 (11.9 %)
Abbreviations: African-Amer African-American, BMI body mass index, Hb
hemoglobin, HTN hypertension, DM diabetes mellitus, CHF congestive heart
failure, CAD coronary artery disease, PVD peripheral vascular disease, CVA
cerebrovascular event, AF atrial fibrillation, ESRD end stage renal disease,
GN glomerulonephritis
aCharacteristics shown as n (%), except for age, which is shown as mean ± 1
standard deviation
b983 (8.9 %) missing values for One Stroke, and 93 (9.6 %) missing values
for > 1 Stroke
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strokes as relatively low, perhaps because of the high mor-
tality associated with an index stroke [10]. However, with
prevalent dialysis patients living substantially longer, on
average, than was the case just a few years ago [2], this
issue of recurrent stroke may take on increasing import-
ance, especially since stroke is strongly related to increas-
ing age [24].
That females on dialysis were substantially more likely
to experience a subsequent ischemic stroke than males
has not, to our knowledge, been specifically reported.
However, insights can be garnered from other work in
both the dialysis and non-dialysis patients populations.
While some studies have suggested that there is no
difference in HR for stroke between males and females
[3, 6], we have previously found females to be at higher
risk of ischemic stroke. Additionally, Power et al. re-
ported the HR for stroke among females to be approxi-
mately 1.25 [8], while Seliger et al. found females to be
more likely to experience a stroke in univariate (HR
1.33), but not multivariable analyses [5]. Recently, the
important role that sex differences might play in stroke
has received increased scrutiny. An analysis by Paulus et
al. [25] suggested that sex differences appear to be im-
portant in risk of ischemic stroke and in post-stroke sur-
vival in the general population. While they found that
females had a reduced risk of mortality after an ischemic
stroke, we observed no such differences (although fe-
males had an increased risk of incurring a subsequent is-
chemic stroke). It may be that epidemiological findings
in the general population, such as those relating to sex,
may not be generalizeable to the HD population, as the
latter have both quantitative and qualitative differences
in stroke risk factors compared to the former.
Another major demographic finding concerned race.
Compared to African-Americans, Caucasians were more
likely to die following a first new ischemic stroke. The
Fig. 3 Transition probability graph for stroke
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issue of survival on dialysis is a complex one, with recent
work suggesting that, at least among older individuals
(who also comprise those most likely to experience
major cardiovascular events such as stroke), African-
Americans had better survival than Caucasians [26]. The
improved survival of racial minorities has also been
demonstrated in other HD populations, such as that of
the UK [27–29]. Racial differences in stroke incidence
may also be related to previous disease burden, since
Seliger et al. reported that differential stroke risk by race
interacts with the presence of previous cardiovascular
disease [5]. If true, this suggests that there are complex-
ities in stroke epidemiology by race in dialysis patients.
Our findings seem to indicate that African-Americans
may survive strokes that Caucasians do not. Whether
this might be due to biological differences, phenotypic
differences in stroke by race, stroke treatment, or other
factors is unknown. More broadly, this phenomenon
may be operative for other cardiovascular events such as
myocardial infarctions or complications of peripheral
vascular disease; if so, the greater ability of black, as op-
posed to white, HD patients to weather catastrophic car-
diovascular events may be a reason for greater longevity
in black, as compared to white, HD patients.
Subsequent ischemic strokes demonstrated a note-
worthy temporal pattern. Multistate models have the ad-
vantage of permitting risks to “compete” against each
other by generating relative transition probabilities at
varying times. This permits inferences to be made about
important clinical questions, such as whether a subse-
quent stroke changes the risk of progression to death
compared to having only one stroke. We found that the
transition probability to a subsequent ischemic stroke
increased over time (particularly during the first
6 months after an initial stroke), peaked at 12 months,
and then declined. Within the framework of the multi-
state model, this later decline is likely the result of an in-
creasing probability of transitioning to death. However,
our findings suggest that, among those who do survive,
risk of subsequent stroke may ultimately begin to de-
cline as time from initial stroke increases.
We were initially uncertain as to the relative effect on
mortality of a subsequent, as compared to a first new, is-
chemic stroke. While the survival plots demonstrated, as
would be expected, that a subsequent stroke has a
marked effect of decreasing survival (an effect which in-
creased proportionately as time from the initial stroke
elapsed), this does not directly address the issue of rela-
tive risk of mortality of first, as compared to subsequent,
strokes. We did find a signal that a subsequent stroke
may confer a greater risk of mortality compared to the
first by ≈ 70 %. However, the odds ratio narrowly missed
the traditional threshold of statistical significance, likely
due to relatively modest number of subsequent strokes,
thus definitive conclusions con not be drawn.
These findings must be appreciated within the context
of an apparent paradox suggested by the HRs of < 1 for
patients with a history of stroke (within, or even before,
Fig. 4 Survival plot after first and subsequent strokes
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the first 90 days of dialysis initiation) associated with the
transition of ischemic stroke to death. This unexpected
finding may be the result of competition with death dur-
ing the first critical 90 days after dialysis initiation: since
the sickest patients are likely the ones who die soonest,
only the healthiest or most resilient are likely to survive
the first 90 days to become observable. Because death is,
in effect, an outcome “competing” with a stroke, a stroke
within the first 90 days of dialysis (or even before dialysis
initiation) appears, upon superficial examination, to be
“protective” for the transition from stroke to death.
Conclusions
This may be the first report on the impact of recurrent
strokes on survival in dialysis patients. However, our
findings should be interpreted in the context of import-
ant limitations. First, our outcomes were based upon
claims, so specific stroke characteristics such as the size
or severity of the stroke are unknown. As a claims-based
analysis, we could study only events which resulted in
an encounter with the healthcare system; strokes that
were clinically silent could not be examined. It is there-
fore likely that a great many strokes which did not result
in overt symptoms are not accounted for in our analysis.
Our claims-based approach also means that patient-level
measures such as blood pressures or laboratory values
were not available. Second, the number of subsequent
strokes, relative to the number of first strokes, was mod-
est. Thus, the effect of subsequent, as compared to a
first new, stroke on mortality demonstrated wide confi-
dence intervals which crossed unity at the lower bound.
This limits the ability to draw “definitive” conclusions,
and so our results should be considered hypothesis-
generating. Third, we do not have detailed knowledge of
changes in treatment which result after a stroke. It could
be possible, for example, that females receive different
types of post-stroke interventions than males, or that
African-Americans are treated differently than Cauca-
sians. Thus, our findings may be the result of differences
in treatment in various clinical scenarios rather than any
inherent differences by sex or race. Another limitation is
the paradox that can result from an index event bias, in
which risk factors which predispose for an initial event
appear to be “protective” against recurrent events [30].
This phenomenon can occur when there is congruence
between the risk factors for the index and recurrent
events, and can result in an underestimation of a the ef-
fect of risk factor on subsequent events [31]. As such,
our estimates of the effect of a previous stroke on death
following a subsequent stroke may not be robust; cau-
tion should be used when making inferences about the
importance of the point estimates. Nonetheless, confidence
in our findings is bolstered by the fact that our modeling
approach resulted in several expected associations,
increasing face validity. For example, increasing age (per
decade) was associated with death after a first or subse-
quent stroke, high BMI appeared to be “protective” in na-
ture, and a diagnosis of diabetes was associated with death
following a first new ischemic stroke. Generalizability may
be limited to US dialysis patients, particularly those who
use Medicare as their primary payer. Finally, we did not
censor patients if they transitioned to peritoneal dialysis,
but change in modality is likely to occur only in a very
modest number of US hemodialysis patients, since when
used, peritoneal dialysis is typically employed as an initial,
or “index”, therapy, in the US.
In summary, females are more likely to experience sub-
sequent strokes than males, and Caucasians are more
likely to die after a first new ischemic stroke than African-
Americans. If the latter finding were to be replicated in
other cardiovascular disorders, it might partially explain
the phenomenon of older African-Americans have better
survival on dialysis than Caucasians. The risk of a transi-
tioning to a subsequent stroke, after having had a first,
demonstrates a pattern of increase until about 1 year,
followed by decrease which is likely the result of “compet-
ing” with the outcome of death. Subsequent strokes may
be associated with a substantial decrease in survival prob-
ability, a relative effect which increases as time since first
stroke elapses. This information may be of assistance to
clinicians when inform hemodialysis patients about the
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